View
2
Download
0
Category
Preview:
Citation preview
About Jianshun Biosciences
Milestones
Shun Luo | FOUNDER, CHAIRMAN, JIANSHUN BIOSCIENCESManagement
Pin Milling
2 Parallel Dry Powder Manufacturing Lines
600 kgInstalled Blending
Capacity
Cell Culture Media Produc on
LanzhouJSBio
PD Lab & Cell Culture Media Facility 1
P2/P3R&D Lab
Designed by CRB Engineers, USA
> 1200 m2
Raw Material Warehouse
cGMPISO 9001
ISO 14001ISO 13485
Compliance
San Francisco, CA, USAPD Lab & USA HQ
ShanghaiJSBioPD Lab & East China S&M Centre
SingaporeBTI Collabora on Lab
HaimenJSBioCell Culture Media Facility 2, Planning
• Shanghai R&D center founded
2011 2012 2013 2014 2015 2016 20182017 2019
• JSB founded• P2/P3 PR&D lab• cGMP manufacturing facility
• Start DPM produc on• 1st Gen CD CHO media launch
• ISO 9001, ISO 14001 cer fica on• CD media for CHO/MDCK/ST/VERO… launch
• Signed coopera on agreement of EB66 with Valneva• NMPA Class 1 medical device
• Na onal Innova on Compe on Honors
• NMPA on-site audit• Vaccine market breakthrough
• As the preferred supplier of many industrial customers
• ISO 9001, ISO 14001, ISO 13485 cer fica on• Cooperate with BTI, Singapore
• CCM 2 facility: capacity scale-up• Overseas market breakthrough• Next genera on CD media project
Dr. Shun Luo is Founder and Chairman of Jianshun Biosciences Co., Ltd. Dr. Luo has more than 25 years of experience in biopharmaceu cal and biotechnology industries. He started his industry career as Principal Inves gator at Ares Serono Group. Later Dr. Luo worked for Beckman Coulter, JRH/SAFC Biosicences, Genentech, and Amgen with increasing responsibili es. His career spans from discovery research, to technology and product development, to late stage process development, and to commercial opera ons.Dr. Luo graduated from Virginia Tech with his Ph.D. in Microbiology and Immunology. He was trained as a postdoc at the Department of Biological Chemistry and Molecular Pharmacology, Dana-Farber Cancer Ins tute, Harvard Medical School.In 2010, Dr. Luo was awarded Science and Technology Innova on award at Amgen (for his work on Mab produc vity of 11g/L at 2000 L scale). He also led a team at Jianshun Biosciences achieved an ATF-based perfusion process at 1.5 g/L/day produc vity recently.
Line-up
本 社
関 西 支 所
ホームページ
〒104-8402 東京都中央区築地6 - 1 9 - 2 0TEL.03(3248)2207 FAX.03(3248)2243〒530-0043 大 阪 市 北 区 天 満 1 - 3 - 2 1TEL.06(6357)2128 FAX.06(6357)2330https://www.nichirei.co.jp/bio/
2020.10
Product List
CD Media for CHO cells (Celkey™)
CD Media, LSM, SFM for Vet Vaccine
* CD: Chemical Defined LSM: Low-Serum Media, SFM: Serum-Free Media
CELL LINE
EB66
Fed-batchCHO-S,CHO-K1,DG44, DXB11…
CD CHO 011, CD CHO 014, CD CHO 017,CD CHO 022, CD CHO 050, CD CHO 051
CD Feed 002, CD Feed 008,CD Feed 009, CD Feed 011
CD EB66PoultryVaccine-
BHK21 BHK21 LSMBHK21 SFMFMDBEFATCC CCL-10
CD CHO 014, CD CHO 051Perfusion
CD Transfection MediumTransfection
VEROPPRVPEDVATCC-CCL81
ST CD STPRV, CSFVTGEV, PEDVATCC CRL-1746
MDBK CD MDBKIBRVBVDV-
MDCK
CD MDCKCD MDCK Production Media
Adenoviruses Expression of recombinant proteins
AIVATCC CCL-34
ISOLATE PRODUCTSAPPLICATION
CELL LINE PRODUCTSAPPLICATION
CELL LINE
PK15 CD PK15
CD VERO
HEK293Adeno-virusesATCC CRL-1573 CD HEK293
Sf9/sf21 - Insect SFM
HS - HS SFM
PCV, TEGVPPVATCC CCL-33
ISOLATE PRODUCTSAPPLICATION
Base Media Feed Media
株式会社ニチレイバイオサイエンスでは、長年にわたり細胞培養関連製品を取り扱ってまいりました経験がございます。J ian shun B i o s c i ence s の輸入販売元として高品質な培地製品をお届けいたします。
Recommended